JPS55100387A - Octahydropyrazolo*3*44g*quinolines - Google Patents

Octahydropyrazolo*3*44g*quinolines

Info

Publication number
JPS55100387A
JPS55100387A JP8340479A JP8340479A JPS55100387A JP S55100387 A JPS55100387 A JP S55100387A JP 8340479 A JP8340479 A JP 8340479A JP 8340479 A JP8340479 A JP 8340479A JP S55100387 A JPS55100387 A JP S55100387A
Authority
JP
Japan
Prior art keywords
octahydropyrazolo
quinolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8340479A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6231717B2 (OSRAM
Inventor
Shii Koonfuerudo Edomondo
Jiei Batsuha Nikorai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS55100387A publication Critical patent/JPS55100387A/ja
Publication of JPS6231717B2 publication Critical patent/JPS6231717B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
JP8340479A 1979-01-22 1979-06-28 Octahydropyrazolo*3*44g*quinolines Granted JPS55100387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US506179A 1979-01-22 1979-01-22

Publications (2)

Publication Number Publication Date
JPS55100387A true JPS55100387A (en) 1980-07-31
JPS6231717B2 JPS6231717B2 (OSRAM) 1987-07-09

Family

ID=21713955

Family Applications (2)

Application Number Title Priority Date Filing Date
JP8340479A Granted JPS55100387A (en) 1979-01-22 1979-06-28 Octahydropyrazolo*3*44g*quinolines
JP62025530A Pending JPS6322073A (ja) 1979-01-22 1987-02-05 ６−オキソキノリン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62025530A Pending JPS6322073A (ja) 1979-01-22 1987-02-05 ６−オキソキノリン化合物

Country Status (8)

Country Link
JP (2) JPS55100387A (OSRAM)
KR (1) KR840002068B1 (OSRAM)
AT (1) AT372947B (OSRAM)
BE (1) BE877327A (OSRAM)
CS (3) CS227009B2 (OSRAM)
HU (2) HU180234B (OSRAM)
PL (1) PL126234B1 (OSRAM)
SU (3) SU1360586A3 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222477A (ja) * 1983-05-31 1984-12-14 イーライ・リリー・アンド・カンパニー トランス−ｄｌ−１−アルキル−６−アルコキシオクタヒドロキノリン

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472998A (en) * 1994-09-16 1995-12-05 E. I. Du Pont De Nemours And Company Polymeric additive for cathodic electrocoating compositions for improved throw power
JP2000505046A (ja) * 1995-08-18 2000-04-25 パーデュー・リサーチ・ファウンデーション ドーパミン受容体リガンドとしての新規の融合イソキノリン類

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222477A (ja) * 1983-05-31 1984-12-14 イーライ・リリー・アンド・カンパニー トランス−ｄｌ−１−アルキル−６−アルコキシオクタヒドロキノリン

Also Published As

Publication number Publication date
SU986295A3 (ru) 1982-12-30
SU1360586A3 (ru) 1987-12-15
HU180234B (en) 1983-02-28
CS237331B2 (en) 1985-07-16
CS515881A2 (en) 1985-09-17
HU190390B (en) 1986-07-28
CS443982A2 (cs) 1984-12-14
KR840002068B1 (ko) 1984-11-09
CS227009B2 (en) 1984-04-16
BE877327A (fr) 1979-12-28
PL126234B1 (en) 1983-07-30
JPS6322073A (ja) 1988-01-29
ATA21781A (de) 1983-04-15
AT372947B (de) 1983-11-25
JPS6231717B2 (OSRAM) 1987-07-09
KR830010076A (ko) 1983-12-26
SU1024008A3 (ru) 1983-06-15

Similar Documents

Publication Publication Date Title
CS345184A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
EP0031796A3 (en) 4-heterocyclyl-4'-vinyl-stilbenes
JPS56974A (en) Furnace
JPS55118483A (en) 55alkyll22*44cyanophenyl**1*33dioxanes
GB2040065B (en) Microscope
JPS5636485A (en) 2*33dihydroo2*6*77trisubstitutedd55 acylbenzofuran
JPS5695198A (en) Ee55*22halogenovinyl**2**deoxycytidines
JPS5645480A (en) 4**substitutedd4*5**88trialkylpsoralen
CS265980A1 (en) Zpusob torkretovani vyzdivky hutnich agregatu rozptylovym kuzelem
CS660880A2 (en) Zpusob vyroby 2 substituovanych 4 substituovanych kyselin 5 thiazolkarboxylovych
JPS5697276A (en) Alphaaaryll1hh1*2*44triazolee11ethanols
JPS5699475A (en) 11*88quinolyl**22pyrrolidinone
JPS55100385A (en) Octahydroo2hhpyrrolo*3*44g*quinolines
NZ190832A (en) D-2-azaergoline or 2-aza-(8 or 9)-ergolenes
JPS55132611A (en) Furnace
JPS55100387A (en) Octahydropyrazolo*3*44g*quinolines
GB8319141D0 (en) 2 6 6-trimethyl-cyclo-hex-3-en-1-one
JPS5681554A (en) 5*88dihydroxyy1*44bis*guanidylamino** anthraquinones
JPS5596290A (en) Microomanipulator
NZ194571A (en) 9 or 11-halo-15 -hydroxy-3 17 -e-homoeburnan-14-ones
GB2054112B (en) Furnace
JPS5654869A (en) Fireeextinguishing substanse
JPS5626874A (en) 6 7 sekoerugorinjudotai sonoseihooyobigaikagobutsuoganjusuruarufua adorenarinsadoseikokashadansayo ketsuatsukokasayo chusushinkeikeiyokuseisayo kokeirensayo chintsusayooyobikopurorakuchinsayoojusuruiy
JPS55153767A (en) 5 6 sekoerugorinjudotai sonoseihonarabinigaijudotaioganjusuruarufuaa adorenarinsadoseikokashadansayo koatsusayo chusushinkeikeiyokuseisayo chinkeisayo chintsusayooyobikopurorakuchinsayoojusuruseiyakug
JPS5677240A (en) 55*2*44difluorophenyl**22hydroxybenzoate